Skip to main content
UC Davis Cancer Care Network

UC Davis Cancer Care Network

News releases

March 2017arrow

Hitting cancer with high-intensity ultrasound and immunotherapy

March 23, 2017

In a new study published today in JCI Insight, UC Davis researchers have shown that combining high-intensity focused ultrasound with two immunotherapies (a PD-1 checkpoint inhibitor and TLR9 agonist) can produce excellent response rates in mouse models of epithelial cancer. They also found that, for the combination to be effective, immunotherapies must come first.

UC Davis music, pet and cuddle therapy programs featured in new KVIE documentary

March 21, 2017

Three UC Davis programs are featured in a new documentary produced by KVIE that explores non-pharmacological approaches to helping people heal.

February 2017arrow

Research linking obesity to immune function and disease gets funding boost

February 23, 2017

Researchers at UC Davis have received $3.2 million in federal funds to further investigate how obesity and inflammation affect the body’s immune system in fighting cancer.

UC Davis study finds mold, bacterial contaminants in medical marijuana samples

February 7, 2017

UC Davis physician researchers have found that medical marijuana contains multiple bacterial and fungal pathogens that may cause serious and even fatal infections. They warn that smoking, vaping or inhaling aerosolized marijuana could pose a grave risk to patients, especially those with leukemia, lymphoma, AIDS or conditions requiring immune-suppressing therapies.

January 2017arrow

UC Davis Cancer Care Network welcomes two new sites

January 26, 2017

The UC Davis Health Cancer Care Network of community oncology programs has expanded to include Barton Health in Lake Tahoe and Ridgecrest Regional Hospital in the southeastern Sierra.

Faulty DNA error correction genes set stage for familial gastric cancer

January 19, 2017

A large team of researchers from UC Davis and several European and Latin American institutions have identified genetic variations that contribute to familial gastric cancer. These inherited mutations, which affect the PALB2, BRCA1 and RAD51C genes and have been implicated in other cancer types, impair a critical DNA repair mechanism called homologous recombination. These findings could improve preventive care, as well as provide targets for new therapies. The study was published last month in the journal Gastroenterology.

Many late-stage lung cancer patients do not get treatment

January 18, 2017

A national study by researchers at UC Davis Comprehensive Cancer Center has found that a significant number of lung cancer patients are not receiving treatment. Based on data between 1998 and 2012 from the National Cancer Database, 21 percent of patients (190,539) with non-small cell lung cancer (NSCLC) received no specific cancer treatment, such as chemotherapy, radiotherapy or surgery. Many of the untreated patients were women, elderly, minorities, low income and uninsured.

World's first total-body PET scanner takes big step forward

January 17, 2017

The UC Davis-based EXPLORER consortium, which aims to build a revolutionary total-body PET (positron emission tomography) scanner, has announced the selection of two industry partners to help build the prototype device. They are United Imaging Healthcare America, a North American subsidiary of Shanghai United Imaging Healthcare, and SensL Technologies of Cork, Ireland.

UC Davis and nation's cancer centers jointly endorse updated HPV vaccine recommendations

January 11, 2017

Recognizing a critical need to improve national vaccination rates for the human papillomavirus (HPV), UC Davis Comprehensive Cancer Center has again united with each of the 69 National Cancer Institute (NCI)-designated cancer centers in issuing a joint statement in support of recently revised recommendations from the U.S. Centers for Disease Control and Prevention (CDC).

UC Davis Health welcomes Beijing medical equipment company

January 9, 2017

UC Davis Health has entered into an agreement with Top Grade Health Care to establish a translational research and development center to advance the treatment of patients with cancer.

December 2016arrow

Immunotherapy improves survival in late-stage lung cancer patients

December 12, 2016

A large trial by UC Davis professor David Gandara has found that the immunotherapy atezolizumab was superior to chemotherapy for patients with advanced non-small-cell lung cancer.

November 2016arrow

Kindness, compassion key to cancer center pharmacy program

November 16, 2016

Jacquelyn Conway, a mother who enjoys taking long walks and cooking organic meals, was told she had invasive breast cancer In August 2012. That began an arduous series of cancer treatments starting with chemotherapy – and a determined approach to survival.

Cancer research pioneer to speak on therapy advances

November 15, 2016

Alan Ashworth, renowned basic cancer scientist and president of the UCSF Helen Diller Comprehensive Cancer Center, will present a talk on synthetic lethal approaches to cancer therapy Nov. 30 at UC Davis.

Breast cancer patients have new surgery option with radioactive seed

November 3, 2016

UC Davis Comprehensive Cancer Center now offers a new technique for breast cancer patients undergoing surgery to remove breast cancer that may improve cosmetic outcomes and the patient’s surgery experience.

October 2016arrow

Terminally ill cancer patients fare poorly after surgery

October 25, 2016

Patients with disseminated advanced cancer who undergo surgery are far more likely to endure long hospital stays and readmissions, referrals to extended care facilities and death, UC Davis researchers have found.

Sexual pain in women after cancer is common, and too often ignored

October 20, 2016

Painful sex in women after cancer treatment is relatively common, often treatable and needs to be addressed by medical providers, a UC Davis oncologist and researcher suggests.

Workshop set for young adults with cancer

October 18, 2016

Young adults dealing with the effects of cancer are invited to attend Pushing Past Cancer, a free day of education and motivation, on Saturday, Nov. 5, from 9:30 a.m. to 5 p.m. at the UC Davis Sacramento campus. The event is open to cancer patients ages 18-40, their support persons and medical professionals.

NIH Precision Medicine Initiative Cohort Program Expands in California

October 13, 2016

The National Institutes of Health (NIH) has named the California Precision Medicine Consortium as a regional medical center group in the national network of health care provider organizations that will implement the Precision Medicine Initiative (PMI) Cohort Program.

Cancer Care Network symposium focuses on precision medicine and end-of-life options

October 4, 2016

More than 80 people attended the 4th annual Cancer Care Network Symposium Saturday at the UC Davis Comprehensive Cancer Center auditorium to explore key topics in cancer care, including the new End of Life Option Act. 

September 2016arrow

Lam obtains major federal grants

September 23, 2016

Kit Lam, professor and chair of the UC Davis Department of Biochemistry and Molecular Medicine, has received two major cancer research grants totaling more than $3 million.

Kit Lam appointed to NCI Board of Scientific Counselors

September 20, 2016

Kit Lam, professor and chair of the UC Davis Department of Biochemistry and Molecular Medicine, has been appointed to the National Cancer Institute’s Basic Science Board of Scientific Counselors (BSC).

Voices of patients and oncologists must be heard, study shows

September 9, 2016

Training oncologists and their patients to have high-quality discussions improves communication, but troubling gaps still exist between the two groups, according to a new study in JAMA Oncology.

Ovarian cancer event ready to "ROC" Sept. 18

September 8, 2016

Marking Ovarian Cancer Awareness Month and the need for more research and education about the disease, Let’s ROC, the annual 5K run is set for Sunday, Sept. 18 at 8 a.m.

Cancer Center oral therapy adherence program wins Innovative Pharmacy Practice Award

September 7, 2016

The cancer center's pharmacist-driven oral anti-cancer medication adherence program, led by Iris C. Zhao, has earned the 2016 California Society of Health System Pharmacist’s (CSHP) Innovative Pharmacy Practice Award.

UC Davis K12 scholars funded for cancer research

September 6, 2016

The National Cancer Institute has again funded the K12 Paul Calabresi Clinical Oncology Training Grant to promote and sustain the development of young cancer scientists from diverse fields and from laboratories and clinics across both UC Davis campuses.

August 2016arrow

IPHI report shows impact of cancer screening in California over past 15 years

August 31, 2016

A new report from the UC Davis Institute for Population Health Improvement (IPHI) shows the impact of cancer screening over the past 15 years, identifying areas where increased screening and other cancer-control efforts would save lives and significantly benefit population health.

Lay educators help boost colorectal screening rates in Hmong

August 26, 2016

Hmong Americans are more likely to understand the importance of colorectal cancer screening and to get screened when they’re provided information by specially trained Hmong lay health educators, new research from UC Davis has found.

UC Davis among the top for cancer, again

August 22, 2016

Becker’s Hospital Review has named UC Davis Health System one of 100 in the country with “great oncology programs.”

UC Davis scientists awarded $1 million grant for prostate cancer research

August 5, 2016

The Prostate Cancer Foundation and Movember, the global charity that has raised hundreds of millions for men’s health research and programs, have delivered $1 million to UC Davis prostate cancer researchers.

July 2016arrow

Hybrid treatment hunts down and kills leukemia cells

July 28, 2016

Researchers at UC Davis and Ionis Pharmaceuticals have developed a hybrid treatment that harnesses a monoclonal antibody to deliver antisense DNA to acute lymphoblastic leukemia (ALL) cells and that may lead to less toxic treatments for the disease.

De Vere White to serve on prestigious NIH panel

July 26, 2016

Ralph de Vere White, who retired in June as director of the UC Davis Comprehensive Cancer Center, has been named to a key committee at the National Institute of Health (NIH).

Player-in-chief

July 21, 2016

The play area in the pediatric infusion center is buzzing with activity. Kids are building, coloring, reading and, most importantly, laughing. Not just patients, but parents and siblings, too. The play area isn’t just a haphazard jumble of donated toys and books, it’s a space specially designed by the cancer center’s resident child life specialist and expert on fun, Ellen Meuchel.

Oncologists and cancer patients often differ in prognosis perceptions

July 14, 2016

Patients with stage III or IV cancer report far more optimistic expectations for survival than their oncologists thought they had communicated, according to new research published today in JAMA Oncology. Effective communication between doctors and their patients who could be nearing the end of their lives is crucial, according to the authors, since this is when quality-of-life decisions merge with discussions about treatment options.

Lily Chiquet Strength Foundation, Inc. honors memory of child with donation

July 14, 2016

Lily Chiquet would have been 4 this week.

June 2016arrow

Endowment for promising students honors de Vere White

June 29, 2016

Ralph de Vere White, who steps down this week after a 32-year career at UC Davis Health System, has been honored with an educational endowment in his name.

Lung cancer patients who have surgery live longer

June 7, 2016

Patients with late-stage, non-small cell lung cancer (NSCLC) who have surgery have better survival rates than those who don’t, but fewer of these patients are undergoing surgery, UC Davis researchers have found.

May 2016arrow

De Vere White to step down as long-time UC Davis Comprehensive Cancer Center director

May 31, 2016

Ralph de Vere White, a beloved urologist and acclaimed researcher who led the UC Davis Comprehensive Cancer to designation by the National Cancer Institute (NCI), steps down as its long-time director on June 29.

Miglioretti awarded $7.5 million to evaluate supplemental breast imaging

May 25, 2016

Diana Miglioretti, UC Davis dean’s professor of biostatistics and an internationally recognized breast cancer screening expert, has received $7.5 million to determine the effectiveness of two supplemental breast screening and diagnostic workup strategies -- digital breast tomosynthesis (3D mammography) and magnetic resonance imaging (MRI) -- used with mammography for cancer detection. Miglioretti’s team also will work to determine whether effectiveness of the screening strategies depends on a woman’s breast density.

National Cancer Institute re-designates the cancer center

May 17, 2016

The National Cancer Institute (NCI) has re-designated the UC Davis Comprehensive Cancer Center “comprehensive,” meaning that it meets stringent criteria in the areas of laboratory, clinical and population-based research, professional and public education and in the dissemination of clinical and public advances to the communities it serves.

Autism and cancer share a remarkable number of risk genes in common

May 3, 2016

Autism and cancer share more than 40 risk genes, suggesting that common mechanisms underlying the functions of some of these genes could conceivably be leveraged to develop therapies not just for cancer but for autism as well, an extensive assessment by researchers with the UC Davis MIND Institute and Comprehensive Cancer Center has found.

Common supplement boosts kidney cancer therapy

May 2, 2016

Researchers at UC Davis have shown that docosahexaenoic acid (DHA), a fatty acid commonly found in fish and fish oil supplements, reduces renal cell carcinoma invasiveness, growth rate, and blood vessel growth when combined with the anti-cancer therapy regorafenib. The study was published in the May issue of the journal Molecular Cancer Therapeutics.

Targeted hepatitis B virus screening effective in addressing infection, liver disease risk

May 2, 2016

A community-based hepatitis B virus screening effort led by UC Davis researchers found that targeted outreach to Asian American populations can identify groups at high risk for infection and direct them to appropriate follow-up care to help prevent the onset of liver diseases, including cancer.

April 2016arrow

SU2C awards Albeck Innovative Research Grant

April 26, 2016

UC Davis molecular biologist John Albeck is among 10 recipients chosen to receive a 2016 Innovative Research Grant (IRG) from Stand Up to Cancer (SU2C), a non-profit that supports innovative, high-risk, high-reward projects to accelerate the pace of cancer research and give patients access to new therapies as quickly as possible.

UC Davis Comprehensive Cancer Center earns new quality certification

April 20, 2016

The UC Davis Comprehensive Cancer Center’s Division of Hematology/Oncology has been recognized by the Quality Oncology Practice Initiative (QOPI) Certification Program for meeting the nation’s highest quality standards for cancer care.

UC Davis expands surgical care for lower GI diseases

April 20, 2016

Linda Farkas, a surgeon and expert in hereditary cancers, has joined UC Davis Health System as a professor of surgery and chief of the newly created Division of Colon and Rectal Surgery.

International Cancer Genome Consortium for Medicine launch announced

April 17, 2016

The International Cancer Genome Consortium (ICGC) today announced plans to launch of the International Cancer Genome Consortium for Medicine (ICGCmed), a new phase in the consortium’s evolution that will link genomics to clinical information and health.

Radiation improves survival in older patients with soft tissue sarcomas

April 11, 2016

UC Davis researchers have shown that radiation therapy following surgery benefits older patients more than their younger counterparts, a surprising finding that could change the way some patients are treated for soft tissue sarcomas (STS).